SIREN : 352949960
TEKNIMED is a French company founded 36 years ago, specialized in the sector Fabrication de matériel médico-chirurgical et dentaire. Based in VIC-EN-BIGORRE (65500), this company of category PME shows in 2023 a revenue of 18.1 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-09
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2023 | 2022 | 2021 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 18 074 645 € | 14 068 030 € | 10 960 070 € | 2 638 656 € | 10 455 890 € | 11 324 131 € | 10 308 531 € | 9 023 850 € | 8 463 821 € | 8 011 256 € |
| Net income | 3 102 383 € | 1 728 278 € | 1 155 736 € | 31 622 € | 974 162 € | 949 456 € | 921 714 € | 559 267 € | 643 421 € | 380 073 € |
| EBITDA | 5 003 691 € | 2 733 129 € | 2 082 918 € | 268 795 € | 1 647 835 € | 1 804 843 € | 1 981 803 € | 1 137 752 € | 1 301 344 € | 1 087 432 € |
| Net margin | 17.2% | 12.3% | 10.5% | 1.2% | 9.3% | 8.4% | 8.9% | 6.2% | 7.6% | 4.7% |
In 2023, TEKNIMED achieves revenue of 18.1 M€. Over the period 2015-2023, the company shows strong growth with a CAGR (compound annual growth rate) of +10.7%. Vs 2022, growth of +28% (14.1 M€ -> 18.1 M€). After deducting consumption (5.4 M€), gross margin stands at 12.7 M€, i.e. a rate of 70%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 5.0 M€, representing 27.7% of revenue. Positive scissor effect: EBITDA margin improves by +8.3 pts, sign of improved operational efficiency. This high EBITDA margin provides strong self-financing capacity and resilience to uncertainties. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 3.1 M€, i.e. 17.2% of revenue. This profit can be retained or distributed to shareholders.
18 074 645 €
12 696 742 €
5 003 691 €
4 059 560 €
3 102 383 €
27.6%
The debt ratio (= Financial debt / Equity x 100) stands at 77%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 46%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 1.6 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability. Cash flow represents 22.2% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.
77.17%
46.11%
22.229%
1.606
31.4%
In 2023, the debt ratio of TEKNIMED (77.17) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2023, the financial autonomy of TEKNIMED (46.1%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
In 2023, the repayment capacity of TEKNIMED (1.61) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
The liquidity ratio (= Current assets / Current liabilities) stands at 383.18. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 6.7x. Operating income very largely covers interest expenses: high safety margin.
383.181
6.682
In 2023, the liquidity ratio of TEKNIMED (383.18) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
In 2023, the interest coverage of TEKNIMED (6.7x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 44 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 67 days. Favorable situation: supplier credit is longer than customer credit by 23 days. Inventory turnover is 103 days (= Average inventory / Cost of goods x 360). This high level ties up cash and potentially creates obsolescence risk. Overall, WCR represents 189 days of revenue, i.e. 9.5 M€ to permanently finance. Over 2015-2023, WCR increased by +173%, requiring additional financing.
9 488 466 €
44 j
67 j
103 j
189 j
Based on 57 transactions of similar company sales
(all years),
the value of TEKNIMED is estimated at
9 472 660 €
(range 2 259 324€ - 18 048 597€).
With an EBITDA of 5 003 691€, the sector multiple of 2.5x is applied.
The price/revenue ratio is 0.23x
(conservative valuation).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 57 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare TEKNIMED with other companies in the same sector:
Voir toutes les statistiques du secteur Fabrication de matériel médico-chirurgical et dentaire
The revenue of TEKNIMED in 2023 is 18.1 M€.
Yes, TEKNIMED generated a net profit of 3.1 M€ in 2023.
The headquarters of TEKNIMED is located in VIC-EN-BIGORRE (65500), in the department Hautes-Pyrenees.
The tax return of TEKNIMED is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
TEKNIMED operates in the sector Fabrication de matériel médico-chirurgical et dentaire (NAF code 32.50A). See the 'Sector positioning' section above to compare the company with its competitors.